nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—kidney cancer	0.325	1	CbGaD
Cilazapril—ABCB1—Temsirolimus—kidney cancer	0.0771	0.225	CbGbCtD
Cilazapril—ABCB1—Pazopanib—kidney cancer	0.0405	0.118	CbGbCtD
Cilazapril—ABCB1—Dactinomycin—kidney cancer	0.037	0.108	CbGbCtD
Cilazapril—ABCB1—Gemcitabine—kidney cancer	0.0293	0.0856	CbGbCtD
Cilazapril—ABCB1—Erlotinib—kidney cancer	0.0289	0.0845	CbGbCtD
Cilazapril—ACE—renal artery—kidney cancer	0.0283	0.373	CbGeAlD
Cilazapril—ABCB1—Paclitaxel—kidney cancer	0.0264	0.0773	CbGbCtD
Cilazapril—ABCB1—Sorafenib—kidney cancer	0.0235	0.0687	CbGbCtD
Cilazapril—ABCB1—Vinblastine—kidney cancer	0.0232	0.0678	CbGbCtD
Cilazapril—ABCB1—Vincristine—kidney cancer	0.0228	0.0667	CbGbCtD
Cilazapril—ABCB1—Sunitinib—kidney cancer	0.019	0.0557	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—kidney cancer	0.0143	0.0417	CbGbCtD
Cilazapril—ACE—nephron—kidney cancer	0.00989	0.13	CbGeAlD
Cilazapril—ACE—urine—kidney cancer	0.00793	0.105	CbGeAlD
Cilazapril—SLC15A1—nephron tubule—kidney cancer	0.00298	0.0393	CbGeAlD
Cilazapril—SLC15A1—renal system—kidney cancer	0.00271	0.0357	CbGeAlD
Cilazapril—SLC15A1—kidney—kidney cancer	0.00262	0.0345	CbGeAlD
Cilazapril—ACE—nephron tubule—kidney cancer	0.00213	0.0282	CbGeAlD
Cilazapril—ACE—renal system—kidney cancer	0.00194	0.0256	CbGeAlD
Cilazapril—ACE—kidney—kidney cancer	0.00188	0.0248	CbGeAlD
Cilazapril—SLC15A2—nephron tubule—kidney cancer	0.00186	0.0246	CbGeAlD
Cilazapril—ACE—cortex of kidney—kidney cancer	0.00183	0.0241	CbGeAlD
Cilazapril—ACE—gonad—kidney cancer	0.00174	0.023	CbGeAlD
Cilazapril—ACE—cardiac atrium—kidney cancer	0.00174	0.0229	CbGeAlD
Cilazapril—SLC15A2—renal system—kidney cancer	0.00169	0.0223	CbGeAlD
Cilazapril—SLC15A2—kidney—kidney cancer	0.00164	0.0216	CbGeAlD
Cilazapril—SLC15A2—cortex of kidney—kidney cancer	0.00159	0.021	CbGeAlD
Cilazapril—Perindopril—BCHE—kidney cancer	0.000968	0.313	CrCbGaD
Cilazapril—Ramipril—BCHE—kidney cancer	0.000826	0.267	CrCbGaD
Cilazapril—ABCB1—nephron tubule—kidney cancer	0.000751	0.00992	CbGeAlD
Cilazapril—ABCB1—renal system—kidney cancer	0.000683	0.00901	CbGeAlD
Cilazapril—ABCB1—kidney—kidney cancer	0.00066	0.00871	CbGeAlD
Cilazapril—ABCB1—cortex of kidney—kidney cancer	0.000643	0.00849	CbGeAlD
Cilazapril—ABCB1—gonad—kidney cancer	0.000612	0.00808	CbGeAlD
Cilazapril—Perindopril—ABCB1—kidney cancer	0.000379	0.122	CrCbGaD
Cilazapril—Nateglinide—PTGS1—kidney cancer	0.000344	0.111	CrCbGaD
Cilazapril—Lisinopril—ABCB1—kidney cancer	0.000334	0.108	CrCbGaD
Cilazapril—Enalapril—ABCB1—kidney cancer	0.000245	0.0792	CrCbGaD
Cilazapril—Paraesthesia—Gemcitabine—kidney cancer	0.000147	0.000579	CcSEcCtD
Cilazapril—Flushing—Capecitabine—kidney cancer	0.000147	0.000579	CcSEcCtD
Cilazapril—Cardiac disorder—Capecitabine—kidney cancer	0.000147	0.000579	CcSEcCtD
Cilazapril—Cough—Paclitaxel—kidney cancer	0.000147	0.000577	CcSEcCtD
Cilazapril—Asthenia—Sunitinib—kidney cancer	0.000147	0.000577	CcSEcCtD
Cilazapril—Dyspnoea—Gemcitabine—kidney cancer	0.000146	0.000575	CcSEcCtD
Cilazapril—Nausea—Vinblastine—kidney cancer	0.000146	0.000574	CcSEcCtD
Cilazapril—Somnolence—Gemcitabine—kidney cancer	0.000146	0.000573	CcSEcCtD
Cilazapril—Migraine—Doxorubicin—kidney cancer	0.000146	0.000572	CcSEcCtD
Cilazapril—Nausea—Everolimus—kidney cancer	0.000145	0.000572	CcSEcCtD
Cilazapril—Diarrhoea—Sorafenib—kidney cancer	0.000145	0.000572	CcSEcCtD
Cilazapril—Hypertension—Paclitaxel—kidney cancer	0.000145	0.000571	CcSEcCtD
Cilazapril—Pruritus—Sunitinib—kidney cancer	0.000145	0.000569	CcSEcCtD
Cilazapril—Angiopathy—Capecitabine—kidney cancer	0.000144	0.000566	CcSEcCtD
Cilazapril—Immune system disorder—Capecitabine—kidney cancer	0.000143	0.000563	CcSEcCtD
Cilazapril—Chest pain—Paclitaxel—kidney cancer	0.000143	0.000563	CcSEcCtD
Cilazapril—Arthralgia—Paclitaxel—kidney cancer	0.000143	0.000563	CcSEcCtD
Cilazapril—Myalgia—Paclitaxel—kidney cancer	0.000143	0.000563	CcSEcCtD
Cilazapril—Anxiety—Paclitaxel—kidney cancer	0.000143	0.000561	CcSEcCtD
Cilazapril—Face oedema—Doxorubicin—kidney cancer	0.000143	0.000561	CcSEcCtD
Cilazapril—Decreased appetite—Gemcitabine—kidney cancer	0.000143	0.000561	CcSEcCtD
Cilazapril—Hypersensitivity—Dactinomycin—kidney cancer	0.000143	0.000561	CcSEcCtD
Cilazapril—Chills—Capecitabine—kidney cancer	0.000142	0.00056	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000142	0.000559	CcSEcCtD
Cilazapril—Arrhythmia—Capecitabine—kidney cancer	0.000142	0.000557	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000142	0.000557	CcSEcCtD
Cilazapril—Discomfort—Paclitaxel—kidney cancer	0.000142	0.000557	CcSEcCtD
Cilazapril—Fatigue—Gemcitabine—kidney cancer	0.000141	0.000556	CcSEcCtD
Cilazapril—Gastrointestinal pain—Vincristine—kidney cancer	0.000141	0.000556	CcSEcCtD
Cilazapril—Dizziness—Sorafenib—kidney cancer	0.000141	0.000552	CcSEcCtD
Cilazapril—Constipation—Gemcitabine—kidney cancer	0.00014	0.000551	CcSEcCtD
Cilazapril—Pain—Gemcitabine—kidney cancer	0.00014	0.000551	CcSEcCtD
Cilazapril—Nausea—Erlotinib—kidney cancer	0.00014	0.000551	CcSEcCtD
Cilazapril—Alopecia—Capecitabine—kidney cancer	0.00014	0.000551	CcSEcCtD
Cilazapril—Dry mouth—Paclitaxel—kidney cancer	0.00014	0.000551	CcSEcCtD
Cilazapril—Diarrhoea—Sunitinib—kidney cancer	0.00014	0.00055	CcSEcCtD
Cilazapril—Ataxia—Doxorubicin—kidney cancer	0.000139	0.000546	CcSEcCtD
Cilazapril—Asthenia—Dactinomycin—kidney cancer	0.000139	0.000546	CcSEcCtD
Cilazapril—Confusional state—Paclitaxel—kidney cancer	0.000139	0.000544	CcSEcCtD
Cilazapril—Oedema—Paclitaxel—kidney cancer	0.000137	0.00054	CcSEcCtD
Cilazapril—Abdominal pain—Vincristine—kidney cancer	0.000137	0.000537	CcSEcCtD
Cilazapril—Liver function test abnormal—Doxorubicin—kidney cancer	0.000137	0.000537	CcSEcCtD
Cilazapril—Flatulence—Capecitabine—kidney cancer	0.000136	0.000535	CcSEcCtD
Cilazapril—Dysgeusia—Capecitabine—kidney cancer	0.000135	0.000532	CcSEcCtD
Cilazapril—Dizziness—Sunitinib—kidney cancer	0.000135	0.000531	CcSEcCtD
Cilazapril—Feeling abnormal—Gemcitabine—kidney cancer	0.000135	0.000531	CcSEcCtD
Cilazapril—Shock—Paclitaxel—kidney cancer	0.000135	0.000531	CcSEcCtD
Cilazapril—Vomiting—Sorafenib—kidney cancer	0.000135	0.000531	CcSEcCtD
Cilazapril—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000135	0.000531	CcSEcCtD
Cilazapril—Thrombocytopenia—Paclitaxel—kidney cancer	0.000135	0.000529	CcSEcCtD
Cilazapril—Tachycardia—Paclitaxel—kidney cancer	0.000134	0.000527	CcSEcCtD
Cilazapril—Rash—Sorafenib—kidney cancer	0.000134	0.000527	CcSEcCtD
Cilazapril—Dermatitis—Sorafenib—kidney cancer	0.000134	0.000526	CcSEcCtD
Cilazapril—Skin disorder—Paclitaxel—kidney cancer	0.000133	0.000524	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000133	0.000523	CcSEcCtD
Cilazapril—Headache—Sorafenib—kidney cancer	0.000133	0.000523	CcSEcCtD
Cilazapril—Muscle spasms—Capecitabine—kidney cancer	0.000133	0.000522	CcSEcCtD
Cilazapril—Hyperhidrosis—Paclitaxel—kidney cancer	0.000133	0.000522	CcSEcCtD
Cilazapril—Diarrhoea—Dactinomycin—kidney cancer	0.000132	0.000521	CcSEcCtD
Cilazapril—Anorexia—Paclitaxel—kidney cancer	0.000131	0.000515	CcSEcCtD
Cilazapril—Vomiting—Sunitinib—kidney cancer	0.00013	0.000511	CcSEcCtD
Cilazapril—Tremor—Capecitabine—kidney cancer	0.000129	0.000509	CcSEcCtD
Cilazapril—Rash—Sunitinib—kidney cancer	0.000129	0.000507	CcSEcCtD
Cilazapril—Dermatitis—Sunitinib—kidney cancer	0.000129	0.000506	CcSEcCtD
Cilazapril—Hypotension—Paclitaxel—kidney cancer	0.000128	0.000505	CcSEcCtD
Cilazapril—Ill-defined disorder—Capecitabine—kidney cancer	0.000128	0.000504	CcSEcCtD
Cilazapril—Headache—Sunitinib—kidney cancer	0.000128	0.000504	CcSEcCtD
Cilazapril—Anaemia—Capecitabine—kidney cancer	0.000128	0.000502	CcSEcCtD
Cilazapril—Hypersensitivity—Vincristine—kidney cancer	0.000127	0.000501	CcSEcCtD
Cilazapril—Nausea—Sorafenib—kidney cancer	0.000126	0.000496	CcSEcCtD
Cilazapril—Pancreatitis—Doxorubicin—kidney cancer	0.000125	0.000492	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000125	0.000492	CcSEcCtD
Cilazapril—Malaise—Capecitabine—kidney cancer	0.000125	0.00049	CcSEcCtD
Cilazapril—Angina pectoris—Doxorubicin—kidney cancer	0.000125	0.000489	CcSEcCtD
Cilazapril—Insomnia—Paclitaxel—kidney cancer	0.000124	0.000488	CcSEcCtD
Cilazapril—Vertigo—Capecitabine—kidney cancer	0.000124	0.000488	CcSEcCtD
Cilazapril—Asthenia—Vincristine—kidney cancer	0.000124	0.000488	CcSEcCtD
Cilazapril—Syncope—Capecitabine—kidney cancer	0.000124	0.000487	CcSEcCtD
Cilazapril—Leukopenia—Capecitabine—kidney cancer	0.000124	0.000486	CcSEcCtD
Cilazapril—Paraesthesia—Paclitaxel—kidney cancer	0.000123	0.000485	CcSEcCtD
Cilazapril—Vomiting—Dactinomycin—kidney cancer	0.000123	0.000484	CcSEcCtD
Cilazapril—Bronchitis—Doxorubicin—kidney cancer	0.000123	0.000483	CcSEcCtD
Cilazapril—Dyspnoea—Paclitaxel—kidney cancer	0.000122	0.000481	CcSEcCtD
Cilazapril—Somnolence—Paclitaxel—kidney cancer	0.000122	0.00048	CcSEcCtD
Cilazapril—Palpitations—Capecitabine—kidney cancer	0.000122	0.00048	CcSEcCtD
Cilazapril—Rash—Dactinomycin—kidney cancer	0.000122	0.00048	CcSEcCtD
Cilazapril—Nausea—Sunitinib—kidney cancer	0.000121	0.000477	CcSEcCtD
Cilazapril—Loss of consciousness—Capecitabine—kidney cancer	0.000121	0.000477	CcSEcCtD
Cilazapril—Dyspepsia—Paclitaxel—kidney cancer	0.000121	0.000475	CcSEcCtD
Cilazapril—Cough—Capecitabine—kidney cancer	0.000121	0.000474	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—kidney cancer	0.00012	0.00047	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—kidney cancer	0.00012	0.00047	CcSEcCtD
Cilazapril—Decreased appetite—Paclitaxel—kidney cancer	0.000119	0.000469	CcSEcCtD
Cilazapril—Hypertension—Capecitabine—kidney cancer	0.000119	0.000469	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000119	0.000466	CcSEcCtD
Cilazapril—Fatigue—Paclitaxel—kidney cancer	0.000118	0.000466	CcSEcCtD
Cilazapril—Diarrhoea—Vincristine—kidney cancer	0.000118	0.000465	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—kidney cancer	0.000118	0.000464	CcSEcCtD
Cilazapril—Asthenia—Gemcitabine—kidney cancer	0.000118	0.000463	CcSEcCtD
Cilazapril—Chest pain—Capecitabine—kidney cancer	0.000118	0.000462	CcSEcCtD
Cilazapril—Arthralgia—Capecitabine—kidney cancer	0.000118	0.000462	CcSEcCtD
Cilazapril—Myalgia—Capecitabine—kidney cancer	0.000118	0.000462	CcSEcCtD
Cilazapril—Pain—Paclitaxel—kidney cancer	0.000117	0.000462	CcSEcCtD
Cilazapril—Constipation—Paclitaxel—kidney cancer	0.000117	0.000462	CcSEcCtD
Cilazapril—Anxiety—Capecitabine—kidney cancer	0.000117	0.000461	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000117	0.000459	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000117	0.000458	CcSEcCtD
Cilazapril—Discomfort—Capecitabine—kidney cancer	0.000116	0.000457	CcSEcCtD
Cilazapril—Pruritus—Gemcitabine—kidney cancer	0.000116	0.000456	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—kidney cancer	0.000115	0.000453	CcSEcCtD
Cilazapril—Dry mouth—Capecitabine—kidney cancer	0.000115	0.000452	CcSEcCtD
Cilazapril—Nausea—Dactinomycin—kidney cancer	0.000115	0.000452	CcSEcCtD
Cilazapril—Dizziness—Vincristine—kidney cancer	0.000114	0.00045	CcSEcCtD
Cilazapril—Confusional state—Capecitabine—kidney cancer	0.000114	0.000447	CcSEcCtD
Cilazapril—Feeling abnormal—Paclitaxel—kidney cancer	0.000113	0.000445	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000113	0.000444	CcSEcCtD
Cilazapril—Oedema—Capecitabine—kidney cancer	0.000113	0.000443	CcSEcCtD
Cilazapril—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000112	0.000442	CcSEcCtD
Cilazapril—Diarrhoea—Gemcitabine—kidney cancer	0.000112	0.000441	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—kidney cancer	0.000112	0.00044	CcSEcCtD
Cilazapril—Shock—Capecitabine—kidney cancer	0.000111	0.000436	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—kidney cancer	0.000111	0.000435	CcSEcCtD
Cilazapril—Thrombocytopenia—Capecitabine—kidney cancer	0.00011	0.000434	CcSEcCtD
Cilazapril—Tachycardia—Capecitabine—kidney cancer	0.00011	0.000432	CcSEcCtD
Cilazapril—Vomiting—Vincristine—kidney cancer	0.00011	0.000432	CcSEcCtD
Cilazapril—Skin disorder—Capecitabine—kidney cancer	0.00011	0.00043	CcSEcCtD
Cilazapril—Urticaria—Paclitaxel—kidney cancer	0.000109	0.000429	CcSEcCtD
Cilazapril—Rash—Vincristine—kidney cancer	0.000109	0.000429	CcSEcCtD
Cilazapril—Hyperhidrosis—Capecitabine—kidney cancer	0.000109	0.000428	CcSEcCtD
Cilazapril—Dermatitis—Vincristine—kidney cancer	0.000109	0.000428	CcSEcCtD
Cilazapril—Abdominal pain—Paclitaxel—kidney cancer	0.000109	0.000427	CcSEcCtD
Cilazapril—Headache—Vincristine—kidney cancer	0.000108	0.000426	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000108	0.000424	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—kidney cancer	0.000107	0.000422	CcSEcCtD
Cilazapril—Anorexia—Capecitabine—kidney cancer	0.000107	0.000422	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—kidney cancer	0.000107	0.00042	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—kidney cancer	0.000106	0.000418	CcSEcCtD
Cilazapril—Hypotension—Capecitabine—kidney cancer	0.000105	0.000414	CcSEcCtD
Cilazapril—Vomiting—Gemcitabine—kidney cancer	0.000104	0.00041	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—kidney cancer	0.000104	0.000409	CcSEcCtD
Cilazapril—Rash—Gemcitabine—kidney cancer	0.000103	0.000407	CcSEcCtD
Cilazapril—Dermatitis—Gemcitabine—kidney cancer	0.000103	0.000406	CcSEcCtD
Cilazapril—Headache—Gemcitabine—kidney cancer	0.000103	0.000404	CcSEcCtD
Cilazapril—Nausea—Vincristine—kidney cancer	0.000103	0.000404	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000103	0.000404	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—kidney cancer	0.000103	0.000403	CcSEcCtD
Cilazapril—Insomnia—Capecitabine—kidney cancer	0.000102	0.000401	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—kidney cancer	0.000102	0.0004	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—kidney cancer	0.000102	0.000399	CcSEcCtD
Cilazapril—Paraesthesia—Capecitabine—kidney cancer	0.000101	0.000398	CcSEcCtD
Cilazapril—Hypersensitivity—Paclitaxel—kidney cancer	0.000101	0.000398	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—kidney cancer	0.000101	0.000397	CcSEcCtD
Cilazapril—Dyspnoea—Capecitabine—kidney cancer	0.000101	0.000395	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—kidney cancer	0.0001	0.000394	CcSEcCtD
Cilazapril—Dyspepsia—Capecitabine—kidney cancer	9.93e-05	0.00039	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—kidney cancer	9.86e-05	0.000387	CcSEcCtD
Cilazapril—Asthenia—Paclitaxel—kidney cancer	9.86e-05	0.000387	CcSEcCtD
Cilazapril—Decreased appetite—Capecitabine—kidney cancer	9.8e-05	0.000385	CcSEcCtD
Cilazapril—Nausea—Gemcitabine—kidney cancer	9.75e-05	0.000383	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Capecitabine—kidney cancer	9.73e-05	0.000383	CcSEcCtD
Cilazapril—Fatigue—Capecitabine—kidney cancer	9.72e-05	0.000382	CcSEcCtD
Cilazapril—Pruritus—Paclitaxel—kidney cancer	9.72e-05	0.000382	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—kidney cancer	9.67e-05	0.00038	CcSEcCtD
Cilazapril—Pain—Capecitabine—kidney cancer	9.64e-05	0.000379	CcSEcCtD
Cilazapril—Constipation—Capecitabine—kidney cancer	9.64e-05	0.000379	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—kidney cancer	9.54e-05	0.000375	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—kidney cancer	9.49e-05	0.000373	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—kidney cancer	9.49e-05	0.000373	CcSEcCtD
Cilazapril—Diarrhoea—Paclitaxel—kidney cancer	9.4e-05	0.000369	CcSEcCtD
Cilazapril—Feeling abnormal—Capecitabine—kidney cancer	9.29e-05	0.000365	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—kidney cancer	9.28e-05	0.000365	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—kidney cancer	9.24e-05	0.000363	CcSEcCtD
Cilazapril—Gastrointestinal pain—Capecitabine—kidney cancer	9.22e-05	0.000362	CcSEcCtD
Cilazapril—Chills—Doxorubicin—kidney cancer	9.18e-05	0.000361	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—kidney cancer	9.14e-05	0.000359	CcSEcCtD
Cilazapril—Dizziness—Paclitaxel—kidney cancer	9.09e-05	0.000357	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—kidney cancer	9.04e-05	0.000355	CcSEcCtD
Cilazapril—Urticaria—Capecitabine—kidney cancer	8.96e-05	0.000352	CcSEcCtD
Cilazapril—Abdominal pain—Capecitabine—kidney cancer	8.91e-05	0.00035	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—kidney cancer	8.78e-05	0.000345	CcSEcCtD
Cilazapril—Tension—Doxorubicin—kidney cancer	8.74e-05	0.000343	CcSEcCtD
Cilazapril—Vomiting—Paclitaxel—kidney cancer	8.74e-05	0.000343	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—kidney cancer	8.72e-05	0.000343	CcSEcCtD
Cilazapril—Rash—Paclitaxel—kidney cancer	8.66e-05	0.00034	CcSEcCtD
Cilazapril—Dermatitis—Paclitaxel—kidney cancer	8.66e-05	0.00034	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—kidney cancer	8.65e-05	0.00034	CcSEcCtD
Cilazapril—Headache—Paclitaxel—kidney cancer	8.61e-05	0.000338	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—kidney cancer	8.56e-05	0.000336	CcSEcCtD
Cilazapril—Hypersensitivity—Capecitabine—kidney cancer	8.31e-05	0.000326	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—kidney cancer	8.26e-05	0.000325	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—kidney cancer	8.23e-05	0.000323	CcSEcCtD
Cilazapril—Nausea—Paclitaxel—kidney cancer	8.16e-05	0.000321	CcSEcCtD
Cilazapril—Asthenia—Capecitabine—kidney cancer	8.09e-05	0.000318	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—kidney cancer	8.03e-05	0.000316	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—kidney cancer	8e-05	0.000314	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—kidney cancer	7.99e-05	0.000314	CcSEcCtD
Cilazapril—Pruritus—Capecitabine—kidney cancer	7.98e-05	0.000313	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—kidney cancer	7.97e-05	0.000313	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—kidney cancer	7.87e-05	0.000309	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—kidney cancer	7.83e-05	0.000308	CcSEcCtD
Cilazapril—Cough—Doxorubicin—kidney cancer	7.77e-05	0.000305	CcSEcCtD
Cilazapril—Diarrhoea—Capecitabine—kidney cancer	7.71e-05	0.000303	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—kidney cancer	7.69e-05	0.000302	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—kidney cancer	7.58e-05	0.000298	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—kidney cancer	7.58e-05	0.000298	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—kidney cancer	7.58e-05	0.000298	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—kidney cancer	7.56e-05	0.000297	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.53e-05	0.000296	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—kidney cancer	7.49e-05	0.000294	CcSEcCtD
Cilazapril—Dizziness—Capecitabine—kidney cancer	7.46e-05	0.000293	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—kidney cancer	7.42e-05	0.000291	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—kidney cancer	7.33e-05	0.000288	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—kidney cancer	7.27e-05	0.000286	CcSEcCtD
Cilazapril—Vomiting—Capecitabine—kidney cancer	7.17e-05	0.000282	CcSEcCtD
Cilazapril—Shock—Doxorubicin—kidney cancer	7.15e-05	0.000281	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—kidney cancer	7.12e-05	0.00028	CcSEcCtD
Cilazapril—Rash—Capecitabine—kidney cancer	7.11e-05	0.000279	CcSEcCtD
Cilazapril—Dermatitis—Capecitabine—kidney cancer	7.1e-05	0.000279	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—kidney cancer	7.09e-05	0.000279	CcSEcCtD
Cilazapril—Headache—Capecitabine—kidney cancer	7.06e-05	0.000278	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—kidney cancer	7.06e-05	0.000277	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—kidney cancer	7.03e-05	0.000276	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—kidney cancer	6.93e-05	0.000272	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—kidney cancer	6.79e-05	0.000267	CcSEcCtD
Cilazapril—Nausea—Capecitabine—kidney cancer	6.7e-05	0.000263	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.62e-05	0.00026	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—kidney cancer	6.57e-05	0.000258	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—kidney cancer	6.53e-05	0.000256	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—kidney cancer	6.48e-05	0.000255	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—kidney cancer	6.46e-05	0.000254	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—kidney cancer	6.4e-05	0.000251	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—kidney cancer	6.32e-05	0.000248	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.28e-05	0.000247	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—kidney cancer	6.27e-05	0.000246	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—kidney cancer	6.22e-05	0.000244	CcSEcCtD
Cilazapril—Pain—Doxorubicin—kidney cancer	6.22e-05	0.000244	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—kidney cancer	5.99e-05	0.000235	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—kidney cancer	5.94e-05	0.000234	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—kidney cancer	5.77e-05	0.000227	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—kidney cancer	5.75e-05	0.000226	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—kidney cancer	5.36e-05	0.00021	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—kidney cancer	5.21e-05	0.000205	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—kidney cancer	5.14e-05	0.000202	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—kidney cancer	4.97e-05	0.000195	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—kidney cancer	4.81e-05	0.000189	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—kidney cancer	4.62e-05	0.000182	CcSEcCtD
Cilazapril—Rash—Doxorubicin—kidney cancer	4.58e-05	0.00018	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—kidney cancer	4.58e-05	0.00018	CcSEcCtD
Cilazapril—Headache—Doxorubicin—kidney cancer	4.55e-05	0.000179	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—kidney cancer	4.32e-05	0.00017	CcSEcCtD
